1.	A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Subjects With Metastatic Breast Cancer Receiving Standard Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR005143, NCT00338286
2.	A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS Phase: Phase III Type: Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2005-0890, NCT00656448
3.	Anemia Treatment for Advanced NSCLC Patients Receiving Chemotherapy Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20070782, NCT00858364
4.	Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07.0048, NCT00624312
5.	Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TXA127-2007-002, NCT00771810
6.	Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A011-08, NCT00931606
7.	Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer Phase: Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EPOSUR, 20052318, NCT00294203
8.	Pilot Study of High-Dose Epoetin alfa Followed By Maintenance Epoetin alfa in Treating Moderate Anemia in Patients Who Are Undergoing Chemotherapy for Multiple Myeloma Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CASE-CCF-5497, ORTHO-CASE-CCF-5497, NCT00400686